Regula Furegati Hafner: Catalogue data in Autumn Semester 2018 |
| Name | Ms Regula Furegati Hafner |
| Address | Inst. f. Pharmazeutische Wiss. ETH Zürich, HCI H 417 Vladimir-Prelog-Weg 1-5/10 8093 Zürich SWITZERLAND |
| Telephone | +41 44 633 74 05 |
| Fax | +41 44 633 13 65 |
| regula.furegati@pharma.ethz.ch | |
| URL | http://www.postgraduate.pharma.ethz.ch |
| Department | Chemistry and Applied Biosciences |
| Relationship | Lecturer |
| Number | Title | ECTS | Hours | Lecturers | |
|---|---|---|---|---|---|
| 541-0002-00L | Module 2: Project Management in the Pharmaceutical Industry Only for CAS in Pharmaceuticals. The enrolment is done by the CAS in Pharmaceuticals study administration. | 2.5 credits | 3G | R. Schibli, R. Furegati Hafner | |
| Abstract | Pharma Project Management and Communication | ||||
| Learning objective | Project Management Basics: -About projects, project management and the project environment -How to define and plan my project, how to deal with stakeholders and how to manage project risks -Managing my project team, developing the project plan and launching the project -Managing my project team, developing the project plan and launching the project -Monitoring and reporting, project close-out and project leadership -Project evaluation and portfolio management -Budget and resource management Workshop: -Development of a generic drug product in cross-functional project teams Communication: -Intercultural communication -Negotiation skills -Presentation power | ||||
| 541-1000-00L | Essay Only for CAS in Pharmaceuticals. The enrolment is done by the CAS in Pharmaceuticals study administration. | 1 credit | 2D | R. Furegati Hafner, R. Schibli | |
| Abstract | The essay is an essential part of the CAS program „Pharmaceuticals – From Research to Market“ (CAS Pharm) and serves as final performance assessment. | ||||
| Learning objective | The essay documents the student’s competence development during the program as well as the transfer of acquired knowledge to professional practice/activities. | ||||
| Literature | www.postgraduate.pharma.ethz.ch documents: essay | ||||
| 542-0003-00L | Module III: Radiopharmacology and Clinical Radiopharmacy Only for CAS in Radiopharmazeutischer Chemie, Radiopharmacy. The enrolment is done by the CAS study administration. | 4 credits | 6G | R. Schibli, R. Furegati Hafner | |
| Abstract | Participants will understand concepts of Pharmacology, Toxicology and Fundamentals of Nuclear Medicine | ||||
| Learning objective | • Pharmakokinetics and kinetic-modelling • Statistics and practical session • Radiotracers in biochemistry and molecular pharmacology • Selective modification of peptides and proteins to target GPCRs • Demonstration of experimental set up: Peptide and protein modification, radioactive assays in biochemistry • Visit ABX Radeberg • Nuclear medicine: basics and therapy • Immunology • Drug interventions/interactions/adverse reactions • Pharmacology basics, special aspects, clinical studies • Toxicology • Testsystems in toxicology and targeted therapeutics and cucleic acids • Nuclear medicine: clinical diagnostic applications in neurology • Nuclear medicine: visit to SPECT facility and radiopharmaceutical GMP lag (Tc, Ga, therapy) • Radiological imaging modalities- technology and applications • Nuclear medicine: clinical diagnostic applications in oncology • Radiopharmaceutical monographs in the European pharmacopoeia • Practical session, visit: cyclotron, GMP PET production and quality control, PET and PET/CT, therapy unit • Radioligand-binding-assays/autoradiography • In house tours in groups: radioligand-binding-assays, autoradiography, metabolite analytics with LC-MS, cyclotron and radiochemistry, highlights in Leipzig • Biological effects of radiation • Radiotracer transport and blood brain barrier • Radiotracers for neuroimaging | ||||